Skip to main content

Sjogrens

      As we inch closer to a possible vaccine for COVID-19, we are finally filling in the details on how the pandemic is affecting every aspect of our patient’s lives. Are our rheumatic patients at…
      RT @RetamozoSole: Don’t forget to check the eyes. Dr Kolfenbach. Top secret and Pearls #ACR20 @RheumNow It’s also us
      4 years ago
      Don’t forget to check the eyes. Dr Kolfenbach. Top secret and Pearls #ACR20 @RheumNow It’s also useful for dx #sjogren #sarcoidodis #Ig G4 https://t.co/dxmwuwrPqz
      RT @RetamozoSole: Living with #Sjogren #syndrome. Tips for dry mouth management. Dr Papas #ACR20 @RheumNow @ramos_casals
      4 years ago
      Living with #Sjogren #syndrome. Tips for dry mouth management. Dr Papas #ACR20 @RheumNow @ramos_casals https://t.co/uw4NH3yhpn
      RT @RetamozoSole: #sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking,
      4 years ago
      #sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking, cervical lesions, anti La, childhood. https://t.co/QN4FVvQrYN
      RT @RetamozoSole: Management of elderly patients with rheumatic diseases. Dr Rajasimhan. #ACR20 @RheumNow. Also we are n
      4 years ago
      Management of elderly patients with rheumatic diseases. Dr Rajasimhan. #ACR20 @RheumNow. Also we are near of first therapeutic recommendations of elderly #sjogren syndrome @ramos_casals @p_brito_zeron https://t.co/yjGrSTWV1K
      RT @TheLancetRheum: Editors Pick for #ACR20—Leflunomide–hydroxychloroquine combination therapy in patients with prim
      Editors Pick for #ACR20—Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial https://t.co/cunDxVl5XG https://t.co/OGItXCuWDI
      RT @CreakyJoints: Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time i
      Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time in 43% of patients, found an #ACR20 study from @joannamarco @GGRheumdoc + @UW @uofcincy colleagues. “Close monitoring is warranted” to make sure lung function is not declining. https://t.co/MpA0Rq2uVR